Tite J P, Russell S M, Dougan G, O'Callaghan D, Jones I, Brownlee G, Liew F Y
Wellcome Research Laboratories, Beckenham, Kent, England.
J Immunol. 1988 Dec 1;141(11):3980-7.
The gene for the nucleoprotein of the A/NT/60/68 influenza virus was expressed in bacteria and the recombinant protein purified. Lymph node cells from mice immunized with recombinant nucleoprotein proliferated in response to in vitro stimulation with a range of type A influenza viruses. Proliferation was inhibited by mAb to CD4 and class II MHC gene products. IFN-gamma was produced and type-specific CTL were generated in stimulated cultures of immune lymph node cells. These CTL were CD4+ and restricted to class II MHC gene products. Immunization with recombinant nucleoprotein generated Th cells in vivo as measured by the ability to generate an accelerated response to hemagglutinin after challenge with inactivated virus. The results are discussed with reference to a cross-reactive vaccine against influenza.
A/NT/60/68流感病毒核蛋白基因在细菌中表达,并对重组蛋白进行了纯化。用重组核蛋白免疫的小鼠的淋巴结细胞在受到一系列甲型流感病毒的体外刺激后发生增殖。抗CD4单克隆抗体和II类MHC基因产物可抑制增殖。在免疫淋巴结细胞的刺激培养物中产生了干扰素-γ并产生了型特异性CTL。这些CTL是CD4+,并受限于II类MHC基因产物。通过用灭活病毒攻击后对血凝素产生加速反应的能力来衡量,用重组核蛋白免疫可在体内产生Th细胞。结合针对流感的交叉反应疫苗对结果进行了讨论。